Cookie Consent by PrivacyPolicies.com

Publicaciones científicas

178 Publicaciones científicas disponibles

  • Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer

    21 de febrero de 2020 | Revista: Journal of Clinical Oncology

    Delaloge S 1,2, Piccart M 3, Rutgers E 4, Litière S 5, van 't Veer LJ 6, van den Berkmortel F 7, Brain E 8, Dudek-Peric A 5, Gil-Gil M 9, Gomez P 10, Hilbers FS 11, Khalil Z 12, Knox S 13, Kuemmel S 14, Kunz G 15, Lesur A 16, Pierga JY 8,17, Ravdin P 18, Rubio IT 19, Saghatchian M 1, Smilde TJ 20, Thompson AM 21, Viale G 22, Zoppoli G 23, Vuylsteke P 24, Tryfonidis K 5, Poncet C 5, Bogaerts J 5, Cardoso F 25; MINDACT investigators and the TRANSBIG Consortium.

    1 Gustave Roussy, Villejuif, France.
    2 Unicancer Breast Group, Paris, France.
    3 Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
    4 Netherlands Cancer Institute, Amsterdam, the Netherlands.
    5 European Organization for Research and Treatment of Cancer, Brussels, Belgium.
    6 Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.
    7 Zuyderland Medisch Centrum, Heerlen-Geleen, the Netherlands.
    8 Institut Curie-Hôpital Rene Huguenin, Saint-Cloud, France.
    9 Institut Catala D'Oncologia-Institut d'Investigacio Biomedica de Bellvitge, L'Hospitalet, Barcelona, Spain.
    10 Hospital General Vall D'Hebron, Barcelona, Spain.
    11 Breast International Group, Brussels, Belgium.
    12 Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
    13 Europa Donna-The European Breast Cancer Coalition, Milan, Italy.
    14 Breast Unit Kliniken Essen-Mitte, Westdeutsche Studiengruppe, Mönchengladbach, Germany.
    15 St Johannes Hospital, Dortmund, Germany.
    16 Institut de Cancérologie de Lorraine, Vandoeuvre-Les-Nancy, France.
    17 Institut Curie Paris Sciences et Lettres, Université de Paris, Paris, France.
    18 The University of Texas Health Sciences Center, San Antonio, TX.
    19 Clinica Universidad de Navarra-Site Madrid, Madrid, Spain.
    20 Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, the Netherlands.
    21 Baylor University College of Medicine, Houston, TX.
    22 University of Milan and European Institute of Oncology-Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy.
    23 University of Genoa and Azienda Ospedaliera Universitaria San Martino, Genova, Italy.
    24 Centre Hospitalier Universitaire, Université Catholique de Louvain, Namur, Belgium.
    25 Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.


  • DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters?

    24 de septiembre de 2019 | Revista: Cancers

    Ordoñez R (1,2), Martínez-Calle N (1,2), Agirre X (3,4), Prosper F (5,6,7).

    (1) Área de Hemato-Oncología, Centro de Investigación Médica Aplicada, IDISNA, Universidad de Navarra, Avenida Pío XII-55, 31008 Pamplona, Spain.
    (2) Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
    (3) Área de Hemato-Oncología, Centro de Investigación Médica Aplicada, IDISNA, Universidad de Navarra, Avenida Pío XII-55, 31008 Pamplona, Spain.
    (4) Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
    (5) Área de Hemato-Oncología, Centro de Investigación Médica Aplicada, IDISNA, Universidad de Navarra, Avenida Pío XII-55, 31008 Pamplona, Spain.
    (6) Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
    (7) Departamento de Hematología, Clínica Universidad de Navarra, Universidad de Navarra, Avenida Pío XII-36, 31008 Pamplona, Spain.


  • Anisotropic Cryostructured Collagen Scaffolds for Efficient Delivery of RhBMP-2 and Enhanced Bone Regeneration

    24 de septiembre de 2019 | Revista: Materials

    Stuckensen K (1), Lamo-Espinosa JM (2), Muiños-López E (3), Ripalda-Cemboráin P (2,3), López-Martínez T (3), Iglesias E (3), Abizanda G (3), Andreu I (4), Flandes-Iparraguirre M (4), Pons-Villanueva J (2), Elizalde R (4), Nickel J (5), Ewald A (1), Gbureck U (1), Prósper F (3,6), Groll J (7), Granero-Moltó F (8,9)

    (1) Department for Functional Materials in Medicine and Dentistry and Bavarian Polymer Institute, University of Würzburg, D-97070 Würzburg, Germany.
    (2) Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
    (3) Cell Therapy Area. Clínica Universidad de Navarra, 31008 Pamplona, Spain.
    (4) Department of Materials CEIT-TECNUN, Universidad de Navarra, 20018 San Sebastian, Spain.
    (5) Department Tissue Engineering and Regenerative Medicine, University Hospital Würzburg, D-97070 Würzburg, Germany.
    (6) Department of Haematology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
    (7) Department for Functional Materials in Medicine and Dentistry and Bavarian Polymer Institute, University of Würzburg, D-97070 Würzburg, Germany.
    (8) Department of Orthopaedic Surgery and Traumatology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
    (9) Cell Therapy Area. Clínica Universidad de Navarra, 31008 Pamplona, Spain. 


  • Tolerogenic dendritic cell-based treatment for multiple sclerosis

    9 de septiembre de 2019 | Revista: BMJ Open

    Willekens B# (1,2), Presas-Rodríguez S# (3,4), Mansilla MJ (5,6), Derdelinckx J (1,2), Lee WP (7), Nijs G (7), De Laere M (2), Wens I (2), Cras P (1), Parizel P (8), Van Hecke W (9), Ribbens A (9), Billiet T (9), Adams G (10), Couttenye MM 11, Navarro-Barriuso J (5,6), Teniente-Serra A (5,6), Quirant-Sánchez B (5,6), Lopez-Diaz de Cerio A (12,13), Inogés S (12,13), Prosper F (12,14), Kip A (15), Verheij H (15), Gross CC (16,17), Wiendl H (16,17), Van Ham MS (18,19), Ten Brinke A (18,19), Barriocanal AM (20,21), Massuet-Vilamajó A (22), Hens N (23,24), Berneman Z (2,7), Martínez-Cáceres E (5), Cools N# (25,7), Ramo-Tello C# (26); RESTORE consortium.

    (1) Department of Neurology, University Hospital Antwerp, Edegem, Belgium.
    (2) Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp Faculty of Medicine and Health Sciences, Wilrijk, Belgium.
    (3) Multiple Sclerosis Unit, Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
    (4) Department of Medicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallés, Spain.
    (5) Division of Immunology, LCMN, Hospital Universitario Germans Trias i Pujol and Research Institute, Badalona, Spain.
    (6) Department of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Bellaterra, Spain.
    (7) Center for Cell Therapy and Regenerative Medicine, University Hospital Antwerp, Edegem, Belgium.
    (8) Department of Radiology, University Hospital Antwerp, Edegem, Belgium.
    (9) Icometrix NV, Leuven, Belgium.
    (10) C-Clear Partners, Mortsel, Belgium.
    (11) Department of Nephrology, University Hospital Antwerp, Edegem, Belgium.
    (12) Haematology-Cell Therapy Area, clinica universidad de navarra, Pamplona, Spain.
    (13) Immunology and Immunotherapy Department, Clinica Universidad de Navarra, Pamplona, Spain.
    (14) Program of Haematology-Oncology, CIMA, Universidad de Navarra, Pamplona, Spain.
    (15) Lygature, Utrecht, The Netherlands.
    (16) Department of Neurology, University Hospital Munster, Munster, Germany.
    (17) Department of Neurology, University of Munster, Munster, Germany.
    (18) Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands.
    (19) Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
    (20) Clinical Research Polyvalent Unit, Clinial Trial Unit-Spanish Clinical Research Network, Germans Trias i Pujol Health Sciences Research Institute, Badalona, Spain.
    (21) Department of Pharmacology, Therapeutic and Toxicology, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
    (22) Institut de Diagnòstic per la Imatge, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
    (23) Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), Universiteit Hasselt, Hasselt, Belgium.
    (24) Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine & Infectious Disease Institute (VAXINFECTIO) & Center for Statistics, University of Antwerp Faculty of Medicine and Health Sciences, Wilrijk, Belgium.
    (25) Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp Faculty of Medicine and Health Sciences, Wilrijk, Belgium
    (26) Multiple Sclerosis Unit, Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    # Contributed equally

No hay más publicaciones científicas

No hay más páginas para cargar